- Home
- PKST vs ORGO Comparison
PKST vs ORGO Comparison
Compare PKST & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKST
- ORGO
- Stock Information
- Founded
- PKST 2008
- ORGO 1985
- Country
- PKST United States
- ORGO United States
- Employees
- PKST N/A
- ORGO N/A
- Industry
- PKST Real Estate Investment Trusts
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- PKST Real Estate
- ORGO Health Care
- Exchange
- PKST Nasdaq
- ORGO Nasdaq
- Market Cap
- PKST 514.0M
- ORGO 539.1M
- IPO Year
- PKST N/A
- ORGO N/A
- Fundamental
- Price
- PKST $13.77
- ORGO $5.31
- Analyst Decision
- PKST Strong Buy
- ORGO Buy
- Analyst Count
- PKST 2
- ORGO 3
- Target Price
- PKST $17.50
- ORGO $8.00
- AVG Volume (30 Days)
- PKST 193.5K
- ORGO 3.1M
- Earning Date
- PKST 11-05-2025
- ORGO 11-06-2025
- Dividend Yield
- PKST 2.96%
- ORGO N/A
- EPS Growth
- PKST N/A
- ORGO N/A
- EPS
- PKST N/A
- ORGO N/A
- Revenue
- PKST $221,496,000.00
- ORGO $465,218,000.00
- Revenue This Year
- PKST N/A
- ORGO $2.51
- Revenue Next Year
- PKST N/A
- ORGO $25.45
- P/E Ratio
- PKST N/A
- ORGO N/A
- Revenue Growth
- PKST 48.03
- ORGO 2.24
- 52 Week Low
- PKST $10.14
- ORGO $2.61
- 52 Week High
- PKST $15.40
- ORGO $7.08
- Technical
- Relative Strength Index (RSI)
- PKST 48.19
- ORGO 53.48
- Support Level
- PKST $13.00
- ORGO $5.09
- Resistance Level
- PKST $14.19
- ORGO $5.83
- Average True Range (ATR)
- PKST 0.69
- ORGO 0.55
- MACD
- PKST -0.11
- ORGO -0.05
- Stochastic Oscillator
- PKST 32.02
- ORGO 45.72
About PKST Peakstone Realty Trust
Peakstone Realty Trust is an internally managed, publicly registered real estate investment trust (REIT) that owns and operates predominately single-tenant industrial and office properties with creditworthy tenants and long-term leases. Peakstone's portfolio consists of newer vintage, and well-located real estate assets in majorly high-growth coastal and sunbelt markets. The company has two reportable segments: Industrial and Office. The Industrial segment consists of industrial outdoor storage properties which have a low building-to-land ratio, or low coverage, maximizing yard space for the display, movement, and storage of materials and equipment. The Office segment includes office, R&D and data center properties.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.